Human medicines European public assessment report (EPAR): Kizfizo, temozolomide, Date of refusal: 02/05/2025, Status: Refused
European Medicine Agency (EMA) and European Association for the Study of Diabetes (EASD) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2025, 10:30 (CEST) to 26 September 2025, 12:00 (CEST)
European Medicines Agency (EMA) and European Association for the Study of Diabetes (EASD) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2025, 10:30 (CEST) to 26 September 2025, 12:00 (CEST)
European Medicines Agency (EMA) and European Association of Urology (EAU) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 2 October 2025, 16:30 (CEST) to 2 October 2025, 17:30 (CEST)
Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion
Human medicines European public assessment report (EPAR): Ohtuvayre, ensifentrine, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Insulin Aspart Injection, insulin aspart, Status: Application withdrawn
Summary of opinion: Xerava, 13/11/2025 Positive
Human medicines European public assessment report (EPAR): Enzalutamide Accordpharma, enzalutamide, Status: Opinion
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 November 2025